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Nuclear factor kappa B (NFκB) is an inflammatory transcription factor that plays an
important role in the host immune response to infection. The potential for chlamydiae
to activate NFκB has been an area of interest, however most work has focused on
chlamydiae impacting human health. Given that inflammation characteristic of chlamydial
infection may be associated with severe disease outcomes or contribute to poor overall
fitness in farmed animals, we evaluated the ability of porcine chlamydiae to induce NFκB
activation in vitro. C. pecorum infection induced both NFκB nuclear translocation and
activation at 2 hours post infection (hpi), an effect strongly enhanced by suppression
of host de novo protein synthesis. C. suis and C. trachomatis showed less capacity
for NFκB activation compared to C. pecorum, suggesting a species-specific variation in
NFκB activation. At 24 hpi, C. pecorum induced significant NFκB activation, an effect not
abolished by penicillin (beta lactam)-induced chlamydial stress. C. pecorum-dependent
secretion of interleukin 6 was also detected in the culture supernatant of infected cells
at 24 hpi, and this effect, too, was unchanged by penicillin-induced chlamydial stress.
Taken together, these results suggest that NFκB participates in the early inflammatory
response to C. pecorum and that stressed chlamydiae can promote inflammation.
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INTRODUCTION
The chlamydiae, obligate intracellular Gram-negative bacterial pathogens, cause a broad
range of diseases in non-human animals and humans. All chlamydiae develop inside of a
membrane-delimited compartment termed the inclusion and share a characteristic biphasic
developmental cycle. Infectious elementary bodies (EBs) adhere to and enter host cells, where
they diﬀerentiate into replicative, but non-infectious, reticulate bodies (RBs); RBs divide by
binary fission and diﬀerentiate back into infectious EBs, which exit the cell by lysis or extrusion
(Moulder, 1991; Abdelrahman and Belland, 2005; Hybiske and Stephens, 2007). In vitro, various
stressors, including host immune response factors, nutrient deprivation, beta lactam antibiotic
exposure, or co-infection with viruses or parasites, are capable of interrupting RB replicative
division and maturation to EBs and inducing aberrant body (AB) formation. Upon removal
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of the stressor, normal chlamydial development resumes, and
eventual release of infectious EBs continues. This divergence
from the normal developmental cycle results in a reversible lack
of infectivity, termed chlamydial persistence or the chlamydial
stress response (Hogan et al., 2004; Wyrick, 2010; Schoborg,
2011; Bavoil, 2014). While some chlamydial forms consistent
with AB have been reported in both human (Borel et al.,
2008) and animal (Pospischil et al., 2009) tissue samples, and
chlamydial persistence has been induced experimentally in mice,
wherein it limited the eﬃcacy of subsequent azithromycin
treatment (Phillips Campbell et al., 2012; Phillips-Campbell
et al., 2014), the biological significance of the chlamydial stress
response in natural infections is unknown.
Chlamydiosis encompasses a spectrum of clinical
presentations, from asymptomatic infection, to acute and
fatal disease, to chronic disease associated with sustained or
repeated infection. Chlamydial disease impacts human health
globally, in both developed and developing nations. Chlamydia
trachomatis is the leading cause of infectious blindness
(trachoma) and the most common bacterial sexually transmitted
infection, worldwide (Global incidence and prevalence of
selected curable sexually transmitted infections – 2008; WHO,
2014). In trachoma, eyelid deformation, due to the inflammatory
response to chronic or repeated chlamydial infection, leads to
inturned lashes that damage the cornea and ultimately cause
blindness (Hu et al., 2013). In women, C. trachomatis genital
infection is capable of ascending to the upper reproductive tract,
where chronic inflammation may result in permanent fallopian
tube damage, leading to infertility (Hafner, 2015). Chlamydia
pneumoniae, a highly prevalent agent of respiratory infection,
has also been implicated in the development of atherosclerotic
plaques and subsequent coronary artery and cerebrovascular
disease. In particular, C. pneumoniae infected macrophages
may release cytokines that promote chronic inflammation in
coronary vasculature (Fazio et al., 2009). Thus, inflammation is a
common characteristic of the most detrimental clinical outcomes
of human chlamydial disease.
Chlamydial infection is widespread in economically
important farmed animals and in wild animal populations
as well. Chlamydial disease in the koala, for example, caused
primarily by Chlamydia pecorum, in many ways mirrors C.
trachomatis disease in humans, causing inflammation leading
to blinding ocular disease and urogenital infections associated
with reduced fertility and contributing to population decline
(Polkinghorne et al., 2013). Chronic chlamydial infections are
more common than acute disease outbreaks in agricultural
animals, especially swine and ruminants, are likely to be
asymptomatic and are frequently endemic. Chlamydia suis, the
primary chlamydial species infecting pigs, has been reported
in >90% of Swiss fattening pigs, and was associated with
mild diarrhea but not overt disease (Hoﬀmann et al., 2015).
A range of symptoms, as well as asymptomatic infection,
have also been attributed to various chlamydial species in
pigs, and such infections are expected to have economic
importance (Schautteet and Vanrompay, 2011). Similarly, C.
pecorum, C. abortus, C. psittaci, and C. suis infections are
common in cattle, often in the absence of clinical symptoms,
but may be associated with lack of productivity or fertility
when found in conjunction with various other epidemiological
risk factors (Reinhold et al., 2011). For example, C. pecorum
infections, even when asymptomatic, have been shown to
reduce growth rates in calves by almost 50% (Poudel et al.,
2012). Therefore, in an agricultural setting, inflammation is
also characteristic of chlamydial infection and is not only
associated with severe disease outcomes, but may also contribute
to poor overall fitness with subsequent negative economic
impact.
The inflammatory response, though causative of pathogenesis
in chronic chlamydial disease, is, in fact, vital for host defense
and resolution of infection. Nuclear factor kappa B (NFκB) is an
inflammatory transcription factor that plays an important role
in the host immune response to infection. NFκB is expressed
not only in immune cells, but also in the epithelial cells initially
targeted by Chlamydia and other pathogens, where it can
elicit normal or aberrant induction of epithelial secretion of
inflammatory cytokines, such as interleukin 6 (IL-6) (Alberti
et al., 2012; Hoesel and Schmid, 2013). In mammals, the
NFκB transcription factor is comprised of a family of five
subunits: p65, p50, p52, c-Rel, and Rel B. These subunits
form a series of homodimers and heterodimers which target
a variety of conserved DNA sequences, known as kappa B
binding sites, to elicit both activating and repressing modulation
of a broad range of genes involved in biological processes
including development, immunity, and oncogenesis (Gilmore,
2006; Hayden et al., 2006). Prior to stimulation, inactive NFκB
dimers reside in the cytoplasm, where they are complexed with
members of the IkB family (inhibitors of NFκB). Stimulation
can be mediated by a variety of receptors, including Toll-
like receptors, various interleukin and cytokine receptors, and
antigen receptors (Hoesel and Schmid, 2013). Such stimulation
results, most typically, in the phosphorylation of IkB by the IKK
(IkB kinase) complex, the subsequent proteosomal degradation
of IkB, and the translocation of active NFκB to the nucleus
(Gilmore, 2006).
NFκB is an integral component in selective activation of the
host response to pathogen recognition receptor activation, and is
thus an essential element in the subsequent innate and adaptive
immune responses (Hayden et al., 2006). As such, the potential
for chlamydiae to activate NFκB has been an area of substantial
interest, toward the goal of elucidating the mechanisms of the
damaging inflammatory nature of chlamydial infection. The
majority of this interest has been focused on the chlamydiae
most impacting human health, namely C. pneumoniae and C.
trachomatis, with less frequent evaluation of C. muridarum,
widely used in murine models of chlamydiosis, and zoonotic
C. psittaci. While C. pneumoniae has been consistently reported
to induce NFκB activation in macrophages or smooth muscle
cells, the reports for C. trachomatis have been more variable,
from activation of NFκB to chlamydial-dependent degradation
of NFκB, with evaluation encompassing a broad array of cells
types and experimental conditions. Moreover, the observation
that chlamydial protease activity factor (CPAF) degrades various
host proteins, including the NFκB p65 subunit, during routine
cell lysis and sample processing has further confounded eﬀorts to
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clarify the role of NFκB in Chlamydia-dependent inflammation
(Chen et al., 2012; Tan and Sütterlin, 2014; Johnson et al., 2015).
We aimed to evaluate the ability of porcine chlamydiae
to induce NFκB activation in vitro. C. pecorum induced both
NFκB nuclear translocation and activation at 2 hours post
infection (hpi), an eﬀect strongly enhanced by suppression of
host de novo protein synthesis. C. suis, and the closely related
C. trachomatis (serovar E), showed much reduced capacity for
NFκB activation compared to C. pecorum, indicative of species-
specific variation in the ability to induce NFκB activation. At 24
hpi, C. pecorum induced significant NFκB activation, even in the
absence of experimental inhibition of host protein synthesis—
an eﬀect not abolished by penicillin (beta lactam)-induced
chlamydial stress. Notably, when host protein synthesis was not
inhibited, substantial cytoplasmic localization of active NFκBwas
observed at 24 hpi, similar to recently reported CPAF-dependent
prevention of NFκB nuclear translocation in C. trachomatis
L2 in vitro infection (Patton et al., 2016), suggesting a shared
inhibitory eﬀect on NFκB function among diﬀerent chlamydial
species. C. pecorum-dependent secretion of interleukin 6, a pro-
inflammatory cytokinemodulated by inflammatory transcription
factors including, but not limited to, NFκB was also detected in
the culture supernatant of infected cells at 24 hpi, and this eﬀect,
too, was unchanged by penicillin-induced stress. Taken together,
these results suggest NFκB participates in the early inflammatory
response to C. pecorum. Additionally, penicillin, heavily used in
agriculture, may be expected to induce chlamydial stress, rather
than curing chlamydial infection; our data suggest that such
stressed chlamydiae may still promote inflammation.
MATERIALS AND METHODS
Host Cell Cultivation and Media
HeLa cells are a human cervical adenocarcinoma epithelial cell
line used frequently for porcine chlamydiae studies (Lenart
et al., 2001; Leonard et al., 2016) as well as NFκB activation
studies (Trask, 2004). HeLa cells [CCL-2, American Type Culture
Collection (ATCC), Manassas, VA, USA; provided by Christian
Blenn, Institute of Veterinary Pharmacology and Toxicology,
University of Zurich, Zurich, Switzerland] were cultured at
37◦C, 5% CO2 in growth medium. Growth medium consisted
of Minimal Essential Medium (MEM) with Earle’s salts, 25 mM
HEPES, without L-Glutamine (GIBCO, Thermo Fisher Scientific,
Waltham, MA, USA) supplemented with 10% fetal calf serum
(FCS, BioConcept, Allschwil, Switzerland), 4 mM GlutaMAX-I
(200 mM, GIBCO), and 1% MEM Non-Essential Amino Acids
(100x, GIBCO).
For immunofluorescence (IF) microscopy, cells were seeded
at 1 × 105 cells/well in 24-well plates [Techno Plastic Products
AG (TPP), Trasadingen, Switzerland] in 1 mL/well growth
medium on 13 mm diameter glass coverslips (Sterilin Limited;
Thermo Fisher Scientific, Cambridge, UK). For NFκB activation
assay, interleukin-6 enzyme-linked immunosorbent assay (IL-6
ELISA) and associated Western blots, cells were seeded at 3 ×
106 cells/dish in 100 mm dishes (TPP) in 10 mL/dish growth
medium. For 8 M urea lysis and associated Western blots, cells
were seeded at 3.65 × 105 cells in 6-well plates (TPP) in 3
mL/well growth medium. In all culture formats, seeding density
was equal to 4–5 × 104 cells/cm2. Cells were cultured 36–48 h,
until monolayers approached confluence, for subsequent use in
experiments.
Vero 76 cells (African green monkey kidney epithelial
cells, CRL-1587, ATCC) and Caco-2 cells (human colorectal
adenocarcinoma epithelial cells, HTB-37, ATCC), used in
preliminary immunofluorescence microscopy experiments, were
cultured and seeded in 24-well plates as described for HeLa cells.
Chlamydial Strains
C. pecorum 1710S, a swine abortion isolate (Kaltenboeck and
Storz, 1992), and Chlamydia suis S45/6, a swine intestinal isolate
(Kaltenboeck et al., 1993), were kindly provided by Professor
J. Storz, Baton Rouge, LA, USA. The C. trachomatis serovar
E isolate (Holt et al., 1967) was provided by Professor R. V.
Schoborg, Johnson City, TN, USA.
All chlamydiae were propagated in HeLa cells in the presence
of cycloheximide (CHX). Resulting crude stocks were generated
by mechanical disruption (scraping into culture medium),
sonication on ice for 10 min (Branson Sonifier 250; Branson
Ultrasonics, Danbury, CT, USA), clearing of cellular debris by
centrifugation at 500 g, 4◦C for 10 min, pelleting of Chlamydia
from the cleared lysates at 10,000 g, 4◦C for 45 min and,
finally, resuspension of Chlamydia in SPG medium prior to
storage at −80◦C. SPG medium consisted of 218 mM sucrose
(Sigma-Aldrich, St. Louis, MO, USA), 3.76 mMKH2PO4 (Sigma-
Aldrich), 7.1 mM K2HPO4 (Merck Eurolab AG, Dietlikon,
Switzerland), and 5 mM GlutaMAX-100 (GIBCO). Aliquots of
stocks of each Chlamydia species were titrated by serial dilution
in HeLa cells to determine specific inclusion-forming units
(IFU)/mL of each species in HeLa cells, and freshly thawed stock
aliquots were used in all experiments.
To generate heat treated/inactivated C. pecorum stocks, crude
stock was boiled for 20 min (Kol et al., 1998) in a boiling water
bath or heated at 75◦C for 30 min (Datta et al., 2014) in a
heat block. Red fluorescent 2 µm latex particles (FluoSphere,
Invitrogen) were used as a source of non-infectious particles in
some experiments.
Mycoplasma Testing
Cell culture supernatants and Chlamydia-infected HeLa
supernatants, both cultured 24–48 h with no antibiotics, were
confirmed free of Mycoplasma contamination using the Venor
GeM OneStep Mycoplasma Detection Kit for Conventional PCR
(Minerva Biolabs GmbH, Berlin, Germany) per manufacturer’s
instructions.
Experimental Design, Host Cell Infection,
and Exposure to Cycloheximide, Penicillin,
or Tumor Necrosis Factor Alpha (See
Figure 1)
Cells, cultured as described, were infected with Chlamydia stocks
at the indicated multiplicity of infection (MOI), defined as
the IFU per cell, as determined by titration in HeLa cells. In
experiments comparing the eﬀects of infection with multiple
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chlamydial species, equivalent IFU per cell were used for all
species. Chlamydial stock was added directly to the growth
medium and plates or dishes were centrifuged at 1,000 g, 25◦C
for 1 h as previously described (Borel et al., 2010). In some
preliminary experiments, as noted in the text, centrifugation
was omitted. After infection, plates or dishes were returned to
37◦C, 5% CO2 without medium change, for 2 h of continued
incubation, or medium was aspirated and replaced with fresh
growth medium and plates or dishes were returned to 37◦C,
5% CO2, for 24 h of incubation. Mock stock, generated from
uninfected HeLa monolayers via the method described for stock
generation, was used for mock-infected control groups. Samples
(fixed cell monolayers, cell lysates, or culture medium) were
collected at 1, 2, 3, or 24 hpi, depending on the experiment. In
selected experiments, the eﬀect of centrifugation was evaluated
and non-centrifuged controls were kept at room temperature,
covered (dark), for 1 h during the parallel centrifugation.
In uninfected host cells exposed to tumor necrosis factor
alpha (TNFa) as a control for nuclear factor kappa B nuclear
(NFκB) translocation/activation, human recombinant TNFa
(Sigma-Aldrich) was reconstituted in filter-sterilized phosphate
buﬀered saline (PBS, Invitrogen, Carlsbad, CA, USA) to a stock
concentration of 10 µg/ml and was added to the existing growth
medium at a final concentration of 20, 50, or 100 ng/ml.
Subsequently, the cells were incubated at 37◦C, 5% CO2 for 45,
60, 90, 120, or 180 min prior to sample collection, depending
on the experiment. Sterile PBS alone served as the control. In
some preliminary experiments, as noted in the text, cells were
exposed to chlamydiae without centrifugation and compared to
cells similarly exposed to TNFa.
In experimental groups exposed to cycloheximide (Sigma-
Aldrich), 100 µg/ml CHX, dissolved in deionized water and filter
sterilized, was added to the existing growth medium, at a final
concentration of 1 or 5 µg/ml, 2 h prior to infection or TNFa
exposure. Sterile water alone was added to CHX non-exposed
groups. In the case of groups incubated for 24 hpi prior to sample
collection, CHX exposure, or water exposure, was maintained in
the fresh growth medium.
In experimental groups exposed to penicillin, penicillin G
sodium salt (Sigma-Aldrich) was dissolved in deionized water
to a stock concentration of 20,000 units (U)/mL, filter-sterilized,
and stored at −20◦C. Aliquots of this stock were thawed and
further diluted in sterile water to a working concentration of
100 U/mL immediately before use. To achieve the final 1 U/ml
penicillin G concentration used in all experiments, the 100 U/ml
working solution was diluted in growth medium of penicillin-
exposed samples and added to uninfected or Chlamydia-infected
HeLa cells immediately prior to further incubation. Sterile water
alone was similarly added to growth medium to generate control
(mock penicillin-exposed) samples.
Immunofluorescence Microscopy and
Semi-Quantitative Analysis
Host cells were fixed with 4% formaldehyde for 1 h and rinsed
with PBS prior to immune labeling. Reagents described herein for
IF staining were dissolved in PBS and used at room temperature.
Prior to primary antibody incubation, cells were exposed to 100
mM glycine for 5 min, followed by 0.1% Triton X-100 for 1
min, and cells were blocked with 0.1% Triton X-100, 1% bovine
serum albumin (BSA; Sigma-Aldrich) for 30 min. Primary and
secondary antibodies were diluted in 0.1% Triton X-100, 1% BSA.
For determination of NFκB localization, the primary
antibody, 1:250 diluted rabbit anti-NFκB p65 (C-20, sc-372;
Santa Cruz Biotechnology, Santa Cruz, CA, USA), was incubated
on cells for 1 h, followed by washing 3 times with PBS, and 45
min incubation with one of two secondary antibodies, depending
on the experiment: 1:500 diluted Alexa Fluor 488-conjugated
goat anti-rabbit or 1:1,000 diluted Alexa Fluor 594-conjugated
goat anti-rabbit (Molecular Probes, Eugene, OR, USA). Host and
chlamydial DNA were labeled with 1 µg/mL 4′,6-diamidino-
2′-phenylindole dihydrochloride (DAPI, Molecular Probes)
included with the diluted secondary antibody. After secondary
antibody incubation, cells were washed 3 times with PBS and
coverslips were mounted on glass slides with FluoreGuard
Mounting (Hard Set, ScyTek Laboratories Inc., Logan, UT, USA)
and stored covered/dark.
Coverslips were evaluated using a Leica DMLB fluorescence
microscope (Leica Microsystems, Wetzlar, Germany) under
oil immersion at 1,000x magnification with a 1,006 objective
(PL FLUOTAR 100x/1.30, OIL, ‘/0.17/D, Leica Microsystems)
and a 106 ocular objective (Leica L-Plan 10x/ 25 M, Leica
Microsystems). Microscopic images were captured using BonTec
software (BonTec, Bonn, Germany) and a UI-2250SE-C-HQ
camera (uEye, IDS Imaging Development Systems GmbH,
Obersulm, Germany). For semi-quantitative analysis of NFκB
nuclear translocation, twenty 1,000x magnification images per
coverslip were randomly selected by closing transmission to
the camera and oculars, moving the stage within the area
of the coverslip, opening transmission to the camera, and
capturing the resulting image. The five most centrally located
cells in each image were scored (100 cells total, per coverslip)
for nuclear translocation as follows: a “negative” (−) nuclear
translocation score was given to cells with NFκB labeling
primarily in the cytoplasm (little to no co-localization of NFκB
with the host cell nucleus), a “positive” (+) nuclear translocation
score was given to cells with NFκB labeling primarily in the
nucleus (little to no co-localization of NFκB with the host
cell cytoplasm), and a score of “intermediate” (=) nuclear
translocation was given to cells with simultaneous NFκB labeling
in both the cytoplasm and nucleus (see Supplemental Figure
2). Results are presented as percent of cells per coverslip
scoring positive, negative, or intermediate NFκB nuclear
translocation.
In the case of simultaneous double IF staining of chlamydiae
and NFκB, 1:200 diluted primary Chlamydiaceae family-specific
mouse monoclonal antibody directed against the chlamydial
lipopolysaccharide (LPS, Clone ACI-P; Progen, Heidelberg,
Germany) was diluted together with the 1:250 diluted primary
rabbit anti-NFκB p65 as a single primary antibody solution,
and 1:1,000 diluted Alexa Fluor 594-conjugated secondary
goat anti-mouse antibody and 1:500 diluted Alexa Fluor 488-
conjugated secondary goat anti-rabbit antibody, plus 1:1,000
diluted DAPI, were included in a single secondary antibody
Frontiers in Cellular and Infection Microbiology | www.frontiersin.org 4 May 2017 | Volume 7 | Article 180
Leonard et al. Chlamydia pecorum Induces NFκB Activation
solution. Analysis and imaging were as described for NFκB single
immunofluorescence staining.
Where host cell nuclei and chlamydial inclusions were
enumerated, twenty 1,000x magnification fields per coverslip
(at least 360 cells) were counted and an inclusion per nucleus
value was generated for each field. Results are presented as mean
nuclei per field or mean inclusions per field (n = 20, ±standard
deviation).
Host Cell Lysis and Growth Medium
Collection
Whole cell, cytoplasmic and nuclear extracts for NFκB activation
detection and Western blotting were generated using reagents
from the TransAM Nuclear Extract Kit and Lysis Buﬀer AM2
from the TransAM NFκB p65 Transcription Factor Assay Kit
(substituted for Nuclear Extract Kit Lysis Buﬀer AM1, as
recommended by the manufacturer for subsequent downstream
use in the NFκB p65 Transcription Factor Assay Kit) per
manufacturer’s instructions (Active Motif, Inc., Carlsbad, CA,
USA).
For cell collection, all collection and storage tubes and cell
scrapers used were thoroughly pre-chilled at −20◦C prior to use
and kept on ice during collection and processing. Centrifuges,
including buckets and inserts, were pre-cooled to 4◦C and all
reagents were kept on ice. The 100 mm dishes were placed
on ice and growth medium was removed and held on ice for
further processing as described below. Cells were washed once
with 5ml PBS supplemented with Phosphatase Inhibitor Cocktail
(PBS/PI), scraped into 3 mL PBS/PI and centrifuged at 200 g, 4◦C
for 5 min to pellet cells. Supernatant PBDS/PI was discarded and
cell pellets were kept on ice for immediate processing to whole
cell or cytoplasmic/nuclear extracts, depending on experiment.
For whole cell extract generation, cell pellets were immediately
thoroughly resuspended, by pipetting, in 300 µl/pellet Complete
Lysis Buﬀer [1% Protease Inhibitor Cocktail (4-benzenesulfonyl
fluoride hydrochloride, Aprotinin, Bestatin, Proteinase Inhibitor
E 64, Leupeptin and Pepstatin A) and 5mMDithiothreitol (DTT)
final concentrations in TransAMNFκB p65 Transcription Factor
Assay Kit Lysis Buﬀer AM2]. Suspended pellets were incubated
on ice, vortexed for 5 s every 10 min for 30 min (i.e., 3 times), and
finally vortexed for 30 additional seconds before centrifugation
at 14,000 g, 4◦C for 20 min. The whole cell fractions, i.e., the
supernatants, were immediately transferred, in aliquots, to chilled
storage tubes and frozen/stored at−80◦C.
For cytoplasmic/nuclear extract generation, cell pellets were
immediately gently resuspended, by pipetting, in 500µl/pellet 1X
Hypotonic Buﬀer and incubated on ice 15 min, at which time 25
µl/tube of Detergent was added and samples were vortexed for
10 s prior to being centrifuged at 14,000 g, 4◦C for 30 s to pellet
host cell nuclei. The cytoplasmic fractions, i.e., the supernatants,
were immediately transferred, in aliquots, to chilled storage tubes
and frozen/stored at −80◦C. The nuclear pellet was kept on ice
for immediate further processing.
For nuclear extract generation, nuclear pellets were
immediately thoroughly resuspended, by pipetting, in 25
µl/pellet Complete Lysis Buﬀer plus 2.5 µl/pellet Detergent,
pellets were vortexed 10 s and incubated on ice, vortexed for
5 s every 10 min for 30 min (i.e., 3 times), and finally vortexed
for 30 additional seconds before centrifugation at 14,000 g, 4◦C
for 10 min. The nuclear fractions, i.e., the supernatants, were
immediately transferred, in aliquots, to chilled storage tubes and
frozen/stored at−80◦C.
For 8M urea lysis, previously reported to strongly limit the
activity of chlamydial proteasome-like activity factor (CPAF),
freshly prepared 8M urea (Sigma-Aldrich) was supplemented
with 325 U/mL final concentration of Benzonase Nuclease
(Sigma-Aldrich) and used to lyse 6-well plates of HeLa essentially
as described (Chen et al., 2012). Briefly, the 6-well plates were
placed on ice, growth medium was aspirated from wells, cells
were washed with 3 mL/well ice-cold sterile PBS (1X Dulbecco’s
PBS, without calcium or magnesium; GIBCO, Invitrogen), PBS
was aspirated from wells, 1 mL/well 8M urea with 325 U/mL
Benzonase Nuclease was added per well and incubated on ice 10
min, and finally extracts were immediately transferred to chilled
storage tubes and stored at 4◦C. Urea whole cell extracts were
evaluated by Western blot only.
Aliquots of all extracts were evaluated by BCA Protein
Assay Kit (Pierce Biotechnology, Rockford, IL, USA), per
manufacturer’s instructions, using an Epoch 2 Microplate
Spectrophotometer (BioTek Instruments, Inc., Winooski, VT,
USA) and Gen5 software (BioTek Instruments, Inc.).
For growth medium processing and storage (for IL-6 ELISA),
collected growth medium (as described above) was kept on
ice prior to sequential syringe filtration, first with 0.22 µm
filters (TPP) and then with 0.1 µm filters (GE Healthcare, Little
Chalfont, UK), to remove chlamydial RBs and EBs (Buckner
et al., 2013; Marti et al., 2014) prior to being frozen/stored at
-80◦C.
Nuclear Factor Kappa B Activation Assay
The TransAM NFκB p65 Transcription Factor Assay Kit (Active
Motif, Inc.) was used to evaluate NFκB p65 activation in
whole cell, cytoplasmic and nuclear extracts collected at 2
or 24 hpi. The kit contains an ELISA-style 96-well plate
coated with the NFκB consensus site (5′-GGGACTTTCC-3′),
to which active NFκB specifically binds. An NFκB p65 primary
antibody is used for detection, and binds a p65 epitope only
accessible when NFκB is activated and bound to the target
sequence.
Stored extracts were thawed immediately prior to use,
kept on ice, and the assay was performed per manufacturer’s
instructions. Briefly, 15 µg of extract per well was diluted
in 20 µl Complete Binding Buﬀer (10 ng/mL Herring sperm
DNA and 2mM DTT final concentrations in Binding Buﬀer
AM3) and this was added to wells containing 30 µl Complete
Binding Buﬀer per well (i.e., added to the wells in 50 µl total
volume per well). After incubation at room temperature for
1 h, well contents were decanted and wells were washed.
Wells were then sequentially incubated with primary and
secondary antibodies (horseradish peroxidase-conjugated
secondary) and Developing Solution. Absorbance was read at
450 nm, with blank subtraction, on an Epoch 2 Microplate
Spectrophotometer (BioTek Instruments, Inc.). Samples were
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assayed in duplicate. The results are presented as blank-
subtracted 450 nm absorbance values set relative to the mock
value.
Interleukin-6 Enzyme-Linked
Immunosorbant Assay (ELISA)
The Qiagen Human IL6 Single Analyte ELISArray Kit (Qiagen,
Hilden, Germany), a standard sandwich ELISA assay, was used
to determine the IL-6 concentration in culture supernatant
(growth medium) collected at 2 or 24 hpi. Stored medium was
thawed immediately prior to use, and the assay was performed
per manufacturer’s instructions. Recommended dilutions of the
provided Antigen Standard diluted in Sample Dilution Buﬀer
1 (final concentration of 1% bovine serum albumin in Sample
Dilution Buﬀer Stock) were used for standard curve generation,
as indicated by the manufacturer for assay of cell culture
supernatant samples. Plates were read on an Epoch 2 Microplate
Spectrophotometer (BioTek Instruments, Inc.) and analyzed
with Gen5 software (BioTek Instruments, Inc.). Samples were
assayed in duplicate. The data were analyzed as IL-6 secretion
relative to uninfected control samples (uninfected samples
exposed to no additives and not subjected to centrifugation) and
results are presented as IL-6 secretion relative to mock-infected
samples.
Western Blot Analysis
Stored TransAmKit-generated whole cell, cytoplasmic or nuclear
extracts and Urea whole cell extracts were moved to ice
immediately before use. Eight micrograms of each extract
was diluted in 4X Laemmli Sample Buﬀer (Bio-Rad, Hercules,
CA, USA) supplemented with DTT (Sigma-Aldrich) to 50
mM DTT final concentration, incubated at 95◦C for 5 min
for protein denaturation, centrifuged 30 s at 14,000 g, and
loaded into 4–20% Mini-PROTEAN TGX Precast Gels (Bio-
Rad). Precision Plus Protein Dual Color Standards (10–250
kDa; Bio-Rad) or PageRuler Plus Prestained Protein Ladder
(10–250 kDa; Thermo Fisher Scientific) were included on each
gel for molecular weight estimation. Proteins were separated
by sodium dodecyl sulfate-polyacrylamide gel electrophoresis
and transferred to nitrocellulose membranes, which were dried
overnight.
Membranes were stained with REVERT Total Protein Stain
(LI-COR Biosciences, Lincoln, NE, USA), per manufacturer’s
instructions, imaged with an Odyssey CLx Infrared Imaging
System and analyzed for total protein signal with Image
Studio Software (both, LI-COR Biosciences) with User-Defined
background method, as recommended by the manufacturer.
Membranes were incubated with REVERT Reversal solution (LI-
COR Biosciences) for 5–10 min and rinsed briefly with water and
processed immediately for immunodetection, as follows.
Membranes were blocked with 1X TBS plus 5% skim milk
at room temperature for 1 h. Antibodies were diluted in
1X TBS plus 0.2% Tween-20 (Sigma-Aldrich) and 5% skim
milk. NFκB p65 was probed with 1:100 diluted rabbit anti-
NFκB p65 primary antibody (same antibody as described
in Immunofluorescence Microscopy and Semi-Quantitative
Analysis Section) overnight at 4◦C and 1:20,000 diluted IRDye
800CW Donkey anti-Rabbit IgG secondary antibody (LI-COR
Biosciences) for 1 h at room temperature. Membranes were
washed 4 times, for 5 min, with 1X TBS plus 0.1% Tween-
20 after primary and secondary antibody incubations and
washed once, for 5 min, with 1X TBS prior to imaging
on an Odyssey CLx Infrared Imaging System and analyzed
for NFκB band protein signal with Image Studio Software
(both, LI-COR Biosciences) with Average background method,
as recommended by the manufacturer. Single, distinct bands
of ∼65 kDa were labeled with the NFκB p65 antibody, as
expected.
Quantitative analysis for each Western blot was performed
by normalizing the NFκB signal to the membrane total protein
signal for each lane as per manufacturer’s recommendation.
Quantitative results are presented as normalized NFκB signal
values.
Statistical Analysis
Statistical analyses were performed using Microsoft Excel.
Significance of the diﬀerence of means was determined by two-
tailed, unpaired t-test and p < 0.05 were considered significant.
p-values were confirmed using the GraphPad QuickCalcs
Web site: http://www.graphpad.com/quickcalcs/ttest1/ (accessed
2016). Unless stated otherwise, results are displayed as means,
±standard deviation, of the results from the stated number of
independent experiments.
RESULTS
Preliminary Experiments and Controls
Immunofluorescence (IF) microscopy was used to evaluate
the ability of porcine chlamydiae species C. suis S45/6 strain
(Kaltenboeck et al., 1993) and C. pecorum 1710S strain and the
human pathogen C. trachomatis serovar E (Holt et al., 1967) to
induce nuclear translocation of the inflammatory transcription
factor NFκB p65 subunit. First, we evaluated HeLa cells, as well
as a human colon carcinoma cell line (Caco-2) and a monkey
kidney epithelial cell line (Vero-76), for response to the known
NFκB activator TNFa (Lowenthal et al., 1989). Exposure to TNFa,
added directly to the culture medium at doses ranging from 20 to
100 ng/mL, induced the expected HeLa p65 nuclear translocation
at 45 min post exposure. Specifically, in mock-exposed cells,
NFκB labeling was largely absent from the nucleus and visible
in the cytoplasm, while in TNFa-exposed cells NFκB labeling
was observed in both the nucleus and cytoplasm. This eﬀect was
similar at 60 min post exposure, but returned to levels equivalent
to mock-exposed cells by 90 min post exposure (Supplemental
Figure 1A). Vero and Caco cells were unresponsive to exposure to
TNFa at these concentrations, during these times (Supplemental
Figure 1B), showing no detectable NFκB nuclear translocation
upon exposure. Thus, HeLa cells were used in all subsequent
assays for this study and NFκB labeling in these cells was
confirmed to be specific (Supplemental Figure 1C). For initial
evaluation of the potential eﬀect of chlamydiae on HeLa NFκB
nuclear translocation, we exposed HeLa to C. pecorum in
the same manner as described for TNFa exposure, by adding
chlamydial stock, at a MOI of 5 inclusion forming units (IFU)
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per cell, directly to the culture medium and incubating for 45
or 60 min. C. pecorum infection failed to induce NFκB nuclear
translocation under these conditions (Supplemental Figure 1C).
Chlamydia Pecorum Induces Nuclear
Factor Kappa B (NFκB) Nuclear
Translocation and Activation Early after
Infection
Pre-exposure to 1 or 5 µg/mL of the Eukaryotic protein synthesis
inhibitor cycloheximide (CHX) for 2 h markedly increased the
degree of NFκB nuclear translocation upon TNFa exposure,
with NFκB labeling observed primarily in the nucleus and
largely absent from the cytoplasm (Supplemental Figure 2A),
representing a more robust translocation than that observed for
TNFa exposure in the absence of cycloheximide (Supplemental
Figure 1A). Initial experiments with 2 h CHX pre-exposure, and a
time range of 1, 2, or 3 h post-exposure, confirmed NFκB nuclear
translocation occurred by 1 h but was more pronounced at 2
and 3 h (not shown). Thus, 2 hpi was selected as the time for
evaluation of NFκB nuclear translocation early after chlamydial
infection (see Experimental Design, Figure 1).
Centrifugation may be used to increase chlamydial uptake
and inclusion formation (Allan and Pearce, 1979; Moulder,
1991). Therefore, centrifugation-assisted infection and CHX pre-
exposure were used simultaneously in an eﬀort to maximize
the potential measurable eﬀect of Chlamydia on NFκB nuclear
translocation. Upon CHX pre-exposure of HeLa with subsequent
centrifugation-assisted infection (MOI of 1 or 5), C. pecorum
induced NFκB nuclear translocation at 2 hpi (Figure 2A) in
a dose-dependent manner. Semi-quantitative IF microscopy
analysis ofC. pecorum,C. suis, andC. trachomatis infection under
these conditions (Figure 2B) showed that C. pecorum infection
induced substantial NFκB nuclear translocation, with 67% of cells
scoring (=) and 26% of cells scoring (+), compared to the mock-
infected control in which only 4% of cells scored (=), and no
FIGURE 1 | Experimental Design. Cycloheximide was added to culture
medium 2h before infection. Chlamydia was added to culture medium
immediately prior to centrifugation or incubation. When centrifugation was
omitted, incubation was continued immediately after addition of Chlamydia.
When centrifugation was a variable, non-centrifuged samples were placed
adjacent to the centrifuge, covered, during the centrifugation. For 2 hpi
experiments, medium was not changed; for 24 hpi experiments, medium was
changed immediately after centrifugation. Penicillin was added to culture
medium after centrifugation. Upon medium change, cycloheximide level was
maintained.
cells scored (+). C. trachomatis and C. suis induced less of an
eﬀect, with 45%(=)/4%(+) and 25%(=), respectively. Omission
of cycloheximide pre-exposure reduced the degree of NFκB
nuclear translocation associated with all three chlamydial species
evaluated, with only C. pecorum [2%(+)/24%(=)] showing
nuclear translocation notably higher than the mock-infected
control. Omission of centrifugation from the infection protocol
had a similar eﬀect on all three chlamydial species, reducing
NFκB nuclear translocation to levels similar to that of the mock-
infected control (Supplemental Figure 3A). To determine if the
observed potentiation of Chlamydia-dependent NFκB nuclear
translocation by centrifugation could be attributed specifically
to chlamydial factors, infection, with CHX pre-exposure and
centrifugation, was carried out using heat treated/inactivated C.
pecorum stock (MOI 5) or 2 µm red fluorescent latex particles.
Neither heat treated/inactivated stocks, nor either concentration
of latex particles, increased NFκB nuclear translocation relative
to mock infection (Supplemental Figure 3B), indicating that
active chlamydiae are required to induce translocation at 2
hpi and inactive/non-infective particles alone are insuﬃcient to
do so. IF microscopy confirmed that centrifugation potentiated
latex particle association with cells, and multiple particles were
associated with all cells observed upon centrifugation (not
shown).
An Enzyme-linked Immunosorbent Assay (ELISA)-style assay
of HeLa lysates (lysed per manufacturer’s instructions specifically
to maintain NFκB activity, see Section Material and Methods)
was used to confirm that early C. pecorum-dependent NFκB
nuclear translocation was associated with the expected increase
in DNA consensus sequence binding activity, specifically of
the p65 subunit. Evaluated as an assay control, exposure to
20 ng/mL TNFa, after 2 h CHX pre-exposure, induced the
expected NFκB activation at 2 h post exposure (Supplemental
Figure 4A). This TNFa-induced activation was most apparent
in the nucleus, where it reached >4 times the mock-exposed
value, as opposed to the cytoplasm, where it reached <2 times
the mock-exposed value, as expected and in agreement with
the IF microscopy findings. Assay of TNFa-induced NFκB
activation in whole cell lysate, >5 times the mock-exposed
value, reflected overall NFκB activation as expected, and whole
cell lysates were selected to further evaluate the eﬀect of C.
pecorum on NFκB activation, with the goal of minimizing lysate
processing time. In agreement with the IF microscopy findings,
C. pecorum infection induced whole cell NFκB activation to
>3 times the mock-infected value (Figure 2C). Similar to the
TNFa control, C. pecorum-infected cytoplasmic and nuclear
lysates showed the expected relatively low (<1.5 times the
mock-infected value) and high (>4 times the mock-infected
value) levels of NFκB activation, respectively (Supplemental
Figure 4B), in agreement with IF microscopy findings. Also
in agreement with the IF microscopy findings, the ability of
C. pecorum to induce NFκB activation was found to be dose
dependent (Supplemental Figure 4C), while C. suis induced
a much less robust eﬀect (Supplemental Figure 4D). Taken
together, these data indicate that C. pecorum induces NFκB
nuclear translocation and activation in HeLa cells early after
infection.
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FIGURE 2 | Chlamydia pecorum Induces Nuclear Factor Kappa B (NFκB) nuclear translocation and activation early after infection. HeLa cells were
pre-exposed (+), or not (−), to 1 (C) or 5 (A,B) µg/mL cycloheximide (CHX) for 2 h, infected using centrifugation with C. pecorum (Cp), C. trachomatis (Ct), or C. suis
(Cs) at a multiplicity of infection (MOI) of 1 or 5 and incubated for 2 h. (A) Immunofluorescence (IF) microscopic analysis, in which NFκB p65 was labeled (green),
showed C. pecorum-dependent NFκB nuclear translocation (CHX+). (B) Semi-quantitative analysis of NFκB nuclear translocation assayed by IF microscopy, wherein
100 cells per group were scored positive (+), intermediate (=), or negative (−) for NFκB nuclear translocation (see Section Material and Methods), showed that C.
pecorum induced the most robust NFκB nuclear translocation of the chlamydial species (MOI 5) evaluated. CHX pre-exposure potentiated Chlamydia-dependent
NFκB nuclear translocation. (C) Quantitative analysis of NFκB activation (CHX +) was measured by an Enzyme-linked Immunosorbent Assay (ELISA)-style assay
wherein NFκB binding the target DNA consensus sequence, immobilized in a plate, was detected by immune labeling of the bound, active NFκB p65 subunit. C.
pecorum infection significantly increased NFκB activation compared to the mock-infected control (n = 3, mean ± standard deviation, *p < 0.05).
Chlamydia pecorum-Induced Nuclear
Factor Kappa B Activation and
Interleukin-6 Secretion Are Detectable at
24 h Post Infection, Effects Not Abolished
By Penicillin-Induced Chlamydial Stress
To determine if the observed C. pecorum-dependent early NFκB
p65 activation of HeLa cells was sustained until a later chlamydial
developmental stage, and to determine if penicillin G (PenG)-
induced chlamydial stress could influence potential activation,
we selected 24 hpi for evaluation of continued NFκB activation.
At this time, inclusions were easily detectable and chlamydial
replication was underway (Supplemental Figures 5A,B). Initial
evaluation of the eﬀect of CHX pre-exposure/exposure (CHX
maintained throughout the experiment) and PenG post-infection
exposure on HeLa and C. pecorum growth/development at 24 hpi
showed that (i) host cell numbers were reduced upon CHX pre-
exposure, as expected, since CHX was maintained throughout
the experiment reducing eukaryotic protein synthesis and thus
cellular division, (ii) inclusions numbers were roughly similar
between CHX-pre-exposed and unexposed groups (∼12.5–13.5
inclusions per 1,000X field) despite the diﬀerence in host cell
numbers, (iii) PenG had no eﬀect on host cell numbers or
inclusion numbers, and (iv) C. pecorum infection did not
cause host cell loss relative to mock infection at 24 hpi. ABs,
indicative of chlamydial stress, were exclusively observed in
PenG-exposed groups, regardless of CHX exposure. Thus, PenG
induced the expected chlamydial stress, as characterized by
AB formation without the prevention of inclusion formation
(Leonard et al., 2016). NFκB nuclear translocation was increased
in C. pecorum-infected HeLa, relative to mock-infected controls,
in both PenG-exposed and unexposed groups (Figure 3A).
Additionally, in both C. pecorum-infected groups, NFκB nuclear
translocation was not restricted to infected cells, but was
observed in both infected and uninfected cells (Figure 3A).
Because inclusions partially obscured determination of NFκB
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FIGURE 3 | Chlamydia pecorum-Induced Nuclear Factor Kappa B (NFκB) Activation and Interleukin-6 Secretion are Detectable 24 hpi, Effects not
Abolished by Penicillin-Induced Chlamydial Stress. HeLa cells were pre-exposed (A) or not (B,C) to 1 µg/mL cycloheximide (CHX) for 2 h, infected using
centrifugation with C. pecorum (Cp) at a multiplicity of infection (MOI) of 1 and incubated until 24 h post infection (hpi) with or without exposure to 1 unit/mL penicillin G
(PenG) in the incubation medium. (A) Representative IF micrographs show NFκB p65 (green) and C. pecorum LPS (red) at 1,000x magnification. White and yellow
arrows indicate the nuclei of cells with and without NFκB nuclear translocation, respectively. White and yellow asterisks indicate chlamydial inclusions in cells with and
without NFκB nuclear translocation, respectively. Scale bar = 10 µm. (B) NFκB activation, specifically of subunit p65, was assayed by an enzyme-linked
immunosorbent assay (ELISA)-style assay of whole cell lysates and showed that C. pecorum significantly induced NFκB activation, regardless of PenG-induced
chlamydial stress (n = 3, mean ± standard deviation, *p < 0.05). (C) Interleukin-6 (IL-6) secretion was assayed by ELISA evaluation of cell culture medium and
showed that C. pecorum significantly induced IL-6 secretion, regardless of PenG-induced chlamydial stress (n = 3, mean ± standard deviation, *p < 0.05).
cytoplasmic localization, making it diﬃcult to determine (+) vs.
(=) NFκB nuclear translocation, semi-quantitative analysis was
not undertaken for 24 hpi groups.
ELISA measurement of NFκB activation was carried out on
whole cell lysates to confirm that C. pecorum-dependent NFκB
nuclear translocation at 24 hpi was associated with the expected
increase of NFκB activation. Infection with the relatively low
MOI of 1 was used in order to limit potential infection-
induced cell lysis, which could trigger danger signaling due
to extracellular detection of normally cytoplasmic components
(Broggi and Granucci, 2014). Such signaling has been shown
to strongly impact C. pecorum development in HeLa (Leonard
et al., 2015). An initial evaluation of the potential requirement
for CHX pre-exposure/exposure for C. pecorum-induced NFκB
activation at 24 hpi was made. While NFκB activation at this
later time was strongly potentiated by CHX, as observed for
the 2 hpi time point, marked activation occurred even in the
absence of CHX (Supplemental Figure 6A). It is notable that CHX
pre-exposure/exposure was associated with an increase in the
mock infection NFκB activation to >2 times the corresponding
value for the CHX unexposed mock-infected group. While
C. pecorum infection in the presence of CHX resulted in an
increase of ∼5 times the CHX pre-exposure/exposure mock-
infected group value. Further evaluation was carried out in
the absence of CHX to allow subsequent evaluation of the
induction of cytokine secretion in the absence of translational
inhibition.C. pecorum infection (centrifugation-assisted), in both
the presence or absence of PenG exposure, similarly increased
NFκB activation to ∼3 times the corresponding mock-infected
value at 24 hpi (Figure 3B). Analysis of 24 hpi C. pecorum-
infectedHeLa cytoplasmic and nuclear lysates showed∼5.5 times
the nuclear NFκB activation of the mock-infected group, and
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∼3 times the cytoplasmic activation of the mock-infected group
(Supplemental Figure 6B).
IL-6 is an inflammatory cytokine, inducible by multiple
factors, including but not limited to NFκB activation, and is
secreted by epithelial cells in response to both naturally occurring
C. trachomatis infection (Refaat et al., 2016) and to in vitro
C. trachomatis infection of HeLa cells (Marti et al., 2014).
Evaluation of HeLa culture supernatants by ELISA (Figure 3C)
showed that IL-6 secretion was induced by C. pecorum infection
(in the absence of CHX) to an average of 540–550 pg/mL,
∼3 times the level of mock-infected HeLa. Neither mock-
infected nor C. pecorum infected values were influenced by
PenG exposure. Similar to the NFκB activation results at 24
hpi, CHX pre-exposure/exposure was associated with an increase
in IL-6 secretion to ∼3 times the corresponding value for the
CHX unexposed mock-infected group; C. pecorum infection
in the presence of CHX also resulted in an increase of IL-
6 secretion relevant to the CHX pre-exposure/exposure mock-
infected group value (Supplemental Figure 6C). These results
demonstrate that exposure of HeLa to CHX does not prevent
induction of subsequent IL-6 secretion, despite the limiting eﬀect
of CHX on protein synthesis and cell division. The increase in IL-
6 secretion upon CHX is not unexpected, as it has been previously
reported that CHX exposure is associated with super induction
of primary response genes such as cytokines, including IL-6, an
eﬀect that may result from both decreased mRNA degradation
and increased transcription of these genes (Herschman, 1991;
Hershko et al., 2004). Collectively, these data indicate that C.
pecorum-induced NFκB activation in HeLa is still detectable at
24 hpi, a time when IL-6 secretion can also be demonstrated;
penicillin-induced chlamydial stress did not abolish either NFκB
activation or IL-6 secretion.
Chlamydia-Infected HeLa Lysates Do Not
Show Decreased Nuclear Factor Kappa B
(NFκB) Levels
The observed marked increases in NFκB p65 activation upon
C. pecorum infection at early and late experimental time points,
which would not be expected if marked degradation of NFκB
p65 were occurring, suggests that significant CPAF-dependent
NFκB p65 degradation was not occurring in our experimental
setting. However, CPAF is known to cleave NFκB p65, has been
demonstrated to be active after standard (protein denaturing) cell
lysis of C. trachomatis infected cells and is capable of degrading
some targets such as golgin-84 even when samples are kept on
ice (Chen et al., 2012). Therefore, we evaluated, by Western
blot analysis,−80◦C stored aliquots of the non-denatured lysates
generated for NFκB activity analysis for evidence of NFκB p65
degradation associated with C. pecorum infection of cells. We
additionally analyzed C. pecorum infected HeLa lysates generated
per a protocol shown to deactivate CPAF (Chen et al., 2012;
Johnson et al., 2015), for comparison. Total protein staining was
carried out on membranes prior to probing for NFκB p65, and
NFκB signals were normalized to total protein signals to allow
quantitative analysis of NFκB p65 (Figures 4A–D). Reduction in
NFκB levels was not associated with chlamydial infection in any
group, regardless of lysis protocol or time post infection of lysis,
suggesting that CPAF activity against NFκB is minimal under the
lysis protocol used herein for NFκB activity analysis.
DISCUSSION
The importance of NFκB in the inflammatory response to
infection is without question. The inflammatory nature of
chlamydial infection and associated disease has prompted
substantial interest in the potential specific role of NFκB in
chlamydial pathogenesis, especially in the context of human-
infecting chlamydial species. But although chlamydial infections
in animals are also common, and similarly inflammatory
in nature, little evaluation of the role of NFκB in the
pathogenesis of agriculturally important chlamydial species has
been undertaken to date. Previous reports of chlamydial species-
specific diﬀerences in NFκB-activating potential (Molestina et al.,
2000; Heine et al., 2003) suggests that NFκB activation is likely
not equivalent amongst the chlamydiae and may represent
distinctions in pathological potential. The aim of this study
was to determine if porcine chlamydial species, such as C.
pecorum and C. suis, are capable of inducing NFκB activation
and inflammatory cytokine secretion in the context of in vitro
infection of epithelial cells.
C. psittaci and C. muridarum, though not well-studied, have
been reported to induce NFκB activation (Heine et al., 2003;
Mackern-Oberti et al., 2006; Shirey et al., 2006; Welter-Stahl
et al., 2006). C. trachomatis and C. pneumoniae, however,
have been well-studied amongst the chlamydiae with regards
to activation of NFκB. C. pneumoniae, an extremely widely
distributed agent of human respiratory infection, as well as an
infectious agent in non-human animals, has also been implicated
in other inflammatory diseases such as atherosclerosis (Leonard
and Borel, 2014) and osteoporosis (Di Pietro et al., 2013). NFκB
activation has been consistently reported in response to C.
pneumoniae infection in vitro, over a wide range of infection
times and in a wide variety of cell types, including epithelial
cells (Gencay et al., 2003), monocytes (Donath et al., 2002),
and especially endothelial cells, where infection is also often
associated with IL-6 induction (Dechend et al., 1999; Kol et al.,
1999; Visseren et al., 2002; Niessner et al., 2003). C. trachomatis,
on the other hand, has been reported both to increase NFκB
activation (Heine et al., 2003; Sellami et al., 2014) or not to
do so (Molestina et al., 2000; Xiao et al., 2005), and even to
degradeNFκB p65 (Lad et al., 2007; Christian et al., 2010), though
this phenomenon was later found to be an artifact of in vitro
proteolysis and not a case of true biological targeting (Chen et al.,
2012). Variations in cell lines, timing post infection of NFκB assay
andNFκB assay used, often varying widely from study to study, as
well as the potential influence of the chlamydial protease CPAF,
may all play a role in the inconsistent findings reported for C.
trachomatis/NFκB studies.
The p65 subunit of NFκB (also known as RelA) is one of the
most common of the five NFκB subunits, along with the p50
subunit, found in the NFκB signaling pathway (Hayden et al.,
2006). NFκB nuclear translocation occurs upon ubiquitination
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FIGURE 4 | Chlamydia-Infected HeLa Lysates Do Not Show Decreased Nuclear Factor Kappa B (NFκB) Levels. HeLa cells were pre-exposed to 1 µg/mL
cycloheximide (CHX), or not, for 2 h, infected using centrifugation with C. pecorum (Cp) or C. suis (Cs) at a multiplicity of infection (MOI) of 1 or 5 and incubated until 2
or 24 h post infection (hpi). In addition to mock-infected controls, extra controls with no CHX added and no centrifugation (Con) were included in some experiments.
Cells were lysed with a commercially available kit intended to maintain NFκB activity (active lysates) or with a urea lysis protocol reported to deactivate chlamydial
protease activity factor (urea lysates). Western blotting was performed on gels loaded with 8 µg lysate protein per lane. After transfer to membranes, total protein
staining (bottom image panels) was carried out on membranes prior to probing for NFκB p65 (top image panels). Graphs show NFκB signals normalized to total
protein signals and bars of graphs correspond, in order, to the lanes of adjacent images. (A,B) 2 hpi, CHX pre-exposure, MOI 1 (Cp1 or not noted) unless indicated as
MOI 5 (Cp5). (C,D) 24 hpi, no CHX, MOI 1. No reduction in NFκB levels was associated with chlamydial infection in any group. Active lysates data shows
representative blots from two experiments and urea lysates data shows blots from single, confirmatory experiments.
and degradation of the inhibitors of NFκB (such as IkBa,
inhibitor kappa B, alpha), which, until activation is initiated,
maintain the localization of NFκB in the cytoplasm (Gilmore,
2006). Thus, translocation of p65 is a useful indicator of
NFκB activation in general. The CPAF was recently shown to
specifically degrade NFκB p65 in vitro during standard host
cell lysis protocols, despite the fact that this cleavage does not
appear to occur within intact host cells (Chen et al., 2012; Tan
and Sütterlin, 2014; Johnson et al., 2015), thus IF microscopy
has the advantage of providing a representative measure of
NFκB activation in the absence of cell lysis. Because studies of
NFκB activation by the chlamydiae must necessarily consider
the potential impact of CPAF activity in assays that utilize
cell lysates, steps were taken in this study to monitor lysates
for potential NFκB degradation. We did not find evidence of
Chlamydia-associated NFκB degradation, and several factors
may have influenced this. First, the nature of the lysis process
used for NFκB assay is not a standard protocol and is designed to
maintain NFκB activity. It is conceivable that this may influence
the NFκB degrading activity of CPAF in these lysates, since it
is yet unknown what factors prevent CPAF-dependent NFκB
degradation in intact cells (Tan and Sütterlin, 2014). Second,
while C. trachomatis-associated NFκB degradation was shown,
depending on the genotype, to begin around 20–24 hpi (Lad
et al., 2007) (now known to almost surely be occurring after
lysis), C. pneumoniae lysates evaluated in parallel did not show
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NFκB degradation until between 30 and 46 hpi. This suggests
that species- and strain-specific diﬀerences in the timing of
CPAF activity are likely, thus C. pecorum CPAF activity may be
associated with later times post infection. And finally, though
CPAF has been shown to remain active at low temperatures
and to withstand conditions which inhibit other proteases (Chen
et al., 2012; Tan and Sütterlin, 2014; Johnson et al., 2015), C.
pecorum CPAF, specifically, may exhibit less proteolytic activity,
at least against NFκB, at low temperatures and under certain
experimental conditions. And while it is possible that undetected
chlamydial-dependent NFκB degradation may have occurred
during NFκB activation assays carried out this study, this would
be expected to result in an underestimation of NFκB activity
and would not change the basic findings of the study- which
demonstrated an increase in NFκB activation attributable to C.
pecorum infection.
That C. trachomatis, and the closely related C. suis, showed
little potential to induce NFκB nuclear translocation early after
infection is not unexpected, given that reports of the inability
of C. trachomatis to induce NFκB activation have been relatively
frequent. The more distantly related C. pecorum was associated
not only with NFκB activation early after infection, but also
with continued NFκB activation at 24 hpi. Notably, C. pecorum
infection causes significant lysis of HeLa cells by 39 hpi, a time
when similar infection with C. trachomatis has little to no lysing
eﬀect on HeLa (Leonard et al., 2015, 2016). The concomitant
induction of IL-6 secretion associated with this C. pecorum-
dependent NFκB activation cannot be directly attributed to
activity of NFκB in the context of this study. However, NFκB
is a known contributor to IL-6 induction and has previously
been shown specifically to play a role in Chlamydia-dependent
IL-6 induction in vitro (Niessner et al., 2003). The findings of
this study support the existence of a relatively robust general
pro-inflammatory eﬀect of C. pecorum on HeLa cells, but do
not specify the target(s) of NFκB transcriptional regulation in
response to chlamydial infection nor clarify the requirement for
NFκB activation in the observed IL-6 induction. The induction
of IL-6 may alternatively, or additionally, be exerted via other
modulators of IL-6 such as NF-IL6, a transcription factor
important in the regulation of expression of IL-6 and other
cytokines such as IL-8 and TNF (Akira et al., 1990). Analysis of
the binding sites of Chlamydia-activated NFκB in HeLa would
identify targets regulated in this model and potentially clarify the
role of NFκB in the observed IL-6 induction.
The failure of heat inactivated C. pecorum and non-infectious
latex particles to cause NFκB nuclear translocation in HeLa at 2
hpi, even with the potentiating eﬀect of CHX and centrifugation,
indicates that viable C. pecorum are required for the NFκB
nuclear translocation demonstrated herein. Previously, heat or
formalin inactivated C. pneumoniae were shown to induce NFκB
nuclear translocation in porcine endothelial cells (Baer et al.,
2003), while heat inactivated C. pneumoniae was incapable of
activating an NFκB luciferase reporter assay in human vascular
endothelial cells (Opitz et al., 2005). This suggests that the host
cells, and potentially the method of NFκB activation assay, may
play a role in the requirement for chlamydial viability in NFκB
activation.
Penicillin-induced chlamydial stress, also termed persistence,
did not significantly reduce C. pecorum-dependent NFκB
activation, nor did it alter IL-6 secretion. This suggests (i) that
either Chlamydia-associated factors responsible for these eﬀects
happen as a result of early events such as cell surface binding,
bacterial uptake or inclusion formation, events that would occur
prior to the induction of penicillin-induced chlamydial stress
(associated with RB division), and/or (ii) that responsible factors
remain active even during chlamydial stress. Evaluation of the
requirement for chlamydial viability after chlamydial uptake
may help clarify this point. Pathogen recognition receptors are
potential players in the NFκB response to C. pecorum observed
early after infection. NFκB signaling is known to occur in
response to stimulation of toll-like receptors, the tumor necrosis
factor receptor and the interleukin-1 receptor (Hoesel and
Schmid, 2013). Chlamydia is recognized by toll-like receptors
2 and 4 in the female genital tract (Leonard and Borel, 2014)
and can modulate both interleukin-1 beta and TNFa receptor
expression in HeLa cells (Shirey and Carlin, 2006), highlighting
the potential involvement of these receptors in Chlamydia-
dependent NFκB activation.
It has been demonstrated that penicillin-induced chlamydial
stress significantly increased IL-6 levels in C. trachomatis E-
infected HeLa cells (Wasson et al., 2012). Another recent
report also indicated that the NOD-2-dependent NFκB activating
capacity of C. trachomatis L2 was significantly potentiated by
ampicillin (beta lactam) exposure, again linking chlamydial stress
with increased inflammatory potential (Packiam et al., 2015).
However, penicillin treatment has also been shown to limit
genital tract inflammatory lesion formation in C. muridarum-
infected mice (Dumoux et al., 2013), a finding inconsistent with
beta lactam-induced chlamydial stress dependent inflammatory
pathogenesis. Additionally, iron deprivation, know to induce
the chlamydial stress response (Hogan et al., 2004), reduced
C. pneumoniae-induced NFκB activation and IL-6 secretion
(Visseren et al., 2002), illustrating the potential for non-
beta lactam-induced chlamydial stress to limit NFκB-associated
inflammation. The variable nature of the reported eﬀects of
chlamydial stress on in vitro NFκB activation and IL-6 secretion
raises the possibility that both chlamydial species and persistence
inducer influence the role that chlamydial stress may play in
NFκB-mediated inflammation.
As described above, CHX exposure increased nuclear
translocation of NFκB in the context of both C. pecorum
productive infection and during the penicillin-induced C.
pecorum stress response. Our finding that CHX exposure
also increased nuclear translocation/activation of NFκB in the
context of TNFa stimulation, as well as chlamydial infection,
strongly suggests that the observed CHX-dependent increase
in NFκB nuclear translocation/activation upon chlamydial
infection is, at least in part, due to eﬀects independent of
chlamydiae/chlamydial infection. We, and others, postulate that
CHX-induced suppression of host cellular protein synthesis
reduces IKB production, allowing increased nuclear transport
of activated NFκB. Though CHX exposure is an artificial
means of suppressing mammalian protein synthesis, suspension
of host cellular protein synthesis could occur in the context
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of in vivo chlamydial infection as well. For example, George
et al. recently demonstrated that chlamydial infection activates
the unfolded protein response (UPR) in infected host cells.
Specifically, chlamydial infection activates the Protein kinase
RNA-activated (PKR)-like ER kinase (PERK) pathway (George
et al., 2017). Because activation of the PERK pathway during
the URP is known to produce a translational blockade
in mammalian cells, it seems plausible that Chlamydia-
induced UPR activation could decrease IKB production and
lead to increased NFκB nuclear translocation in vivo—
at least in chlamydia-infected cells. Furthermore, interferon
gamma (IFN-gamma) is a very well-characterized inducer
of chlamydial stress and AB formation. Unlike penicillin,
which acts by inhibiting chlamydial peptidoglycan synthesis,
IFN-gamma induces chlamydial stress by inducing the host
cellular indoleamine-pyrrole 2,3-dioxygenase (IDO) enzyme,
which reduces cellular L-tryptophan and essentially starves
the developing chlamydiae of this amino acid. Interestingly,
the human IKB alpha protein contains 3 tryptophan residues,
suggesting that its synthesis would also be inhibited in
IDO-expressing cells. Therefore, IFN-gamma-mediated IDO
induction represents an additional mechanism by which
NFκB translocation could be increased in both productively
and persistently Chlamydia-infected cells. Because IFN-gamma
exposure also induces IDO production in uninfected epithelial
cells (Taylor and Feng, 1991), this mechanism would also
be predicted to increase NFκB translocation in uninfected,
bystander cells as well.
The 24 hpi IF microscopic analysis of NFκB localization,
though somewhat diﬃcult to interpret since the presence
of chlamydial inclusions in the cytoplasm slightly obscured
the observation of cytoplasmic NFκB, nevertheless showed,
qualitatively, that NFκB was not predominantly nuclear, but
both nuclear and cytoplasmic, at 24 hpi in the absence of CHX.
This, in addition to the observed 24 hpi C. pecorum-dependent
cytoplasmic NFκB activation in this study, is in line with a
recent report that wild type C. trachomatis is capable of retaining
HeLa NFκB in the cytoplasm at 20 hpi, while CPAF-deficient C.
trachomatis induces marked NFκB nuclear translocation at 20
hpi (Patton et al., 2016). These findings together suggest that
NFκB activated by chlamydiae may nevertheless be retained, to
some degree in the cytoplasm, and may represent a chlamydial
mechanism associated with prevention of the anti-chlamydial
aﬀects of a continued inflammatory response. It is expected
that the chlamydiae, like many other pathogens, have a broad
arsenal of mechanisms to subvert the normal inflammatory
process important to the elimination of infection. Understanding
the induction of inflammation during chlamydial infection may
yet inform important therapeutic targets for the prevention or
resolution of infection, or for limiting the eventual damage
associated with such infections. Furthermore, little is known
about the impact of Chlamydia-associated inflammation in the
absence of overt disease, or the economic implications of such
inflammation the context of farmed animals. The role of NFκB in
chlamydial inflammation thus continues to merit consideration.
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